The 6 most recent market catalysts affecting $ORKA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 23, 2026
Market Technicals
Neutral
Impact 65
10 Health Care Stocks Whale Activity In Today’s Session
The filing highlights unusual options activity, often indicative of 'smart money' positioning ahead of potential price shifts. The presence of both bearish and bullish sentiments a…
Sep 23, 2026
Corporate Catalyst
Bullish
Impact 85
Oruka Therapeutics Says Psoriasis Drug Shows Deepening Efficacy
Oruka Therapeutics announced compelling week 28 data for its psoriasis drug ORKA-001, showing significant improvements in efficacy metrics like PASI 100 and PASI 90, along with a f…
Aug 11, 2026
Corporate Catalyst
Neutral
Impact 55
Guggenheim Reiterates Buy on Oruka Therapeutics, Maintains $200 Price Target
Guggenheim analyst Yatin Suneja reiterated a 'Buy' rating and maintained a $200 price target for Oruka Therapeutics. This action signals continued confidence from a prominent analy…
Aug 11, 2026
Corporate Catalyst
Neutral
Impact 55
BTIG Reiterates Buy on Oruka Therapeutics, Maintains $151 Price Target
BTIG analyst Julian Harrison has reaffirmed a 'Buy' rating and a $151 price target for Oruka Therapeutics (ORKA). This action signals continued confidence from a prominent investme…
Aug 10, 2026
Corporate Catalyst
Bearish
Impact 92
Oruka Therapeutics Q2 EPS $(0.55) Misses $(0.51) Estimate
Oruka Therapeutics (ORKA) announced Q2 earnings that significantly missed analyst expectations, reporting a loss of $(0.55) per share against an estimated $(0.51). This 7.84% miss,…
Jul 13, 2026
Corporate Catalyst
Neutral
Impact 55
BTIG Reiterates Buy on Oruka Therapeutics, Maintains $151 Price Target
BTIG analyst Julian Harrison has reaffirmed a 'Buy' rating and a $151 price target for Oruka Therapeutics (ORKA). This action signals continued confidence from a prominent financia…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.